Identification of genes with allelic imbalance on 6p associated with nasopharyngeal carcinoma in Southern Chinese

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Li, Yan ^a,b   Fu, Li ^a   Wong, Alissa Michelle Go ^a   Fan, Yan Hui ^a,b   Li, Miao Xin ^a,b   Bei, Jin Xin ^c   Jia, Wei Hua ^c   Zeng, Yi Xin ^c   Chan, Danny ^a,b   Cheung, Kenneth M C ^a   Sham, Pak ^a   Chua, Daniel ^a   Guan, Xin Yuan ^a   Song, You Qiang ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Special Administrative Region ^*  (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR 1; 4 AMINOBUTYRIC ACID RECEPTOR; ALANINE; HLA A ANTIGEN; HLA COMPLEX GROUP 9; MESSENGER RNA; NEURAL PRECURSOR CELL EXPRESSED DEVELOPMENTALLY DOWN REGULATED 9; ONCOPROTEIN; THREONINE; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID B RECEPTOR; GABA TYPE B RECEPTOR, SUBUNIT 1; NEDD9 PROTEIN, HUMAN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADOLESCENT; ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; CHINESE; CHROMOSOME 6P; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR BIOPSY; CASE CONTROL STUDY; CHINA; CHROMOSOME 6; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; NASOPHARYNX TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALLELIC IMBALANCE; CASE-CONTROL STUDIES; CHINA; CHROMOSOMES, HUMAN, PAIR 6; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NASOPHARYNGEAL NEOPLASMS; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GABA-B;

EID: 79251649127     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014562     Document Type: Article

References (36)

1. Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. Lancet 365: 2041-2054.
2. McDermott AL, Dutt SN, Watkinson JC (2001) The aetiology of nasopharyngeal carcinoma. Clinical Otolaryngology & Allied Sciences 26: 82-92.
3. Lanier A, Bender T, Talbot M, Wilmeth S, Tschopp C, et al. (1980) Nasopharyngeal carcinoma in alaskan eskimos, indians, and aleuts: A review of cases and study of epstein-barr virus, HLA, and environmental risk factors. Cancer 46: 2100-2106.
4. Ho JH (1978) An epidemiologic and clinical study of nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics 4: 182-198.
5. Chan AT, Teo PM, Johnson PJ (2002) Nasopharyngeal carcinoma. Annals of Oncology 13: 1007-1015.
6. Huang TB, Liu Q, Huang HM, Sumei C (2002) Study on genetic epidemiology of nasopharyngeal carcinoma in Guangdong, China Chinese Journal of Medical Genetics 19: 134-137.
7. Zhou X, Cui J, Macias V, Kajdacsy-Balla AA, Ye H, et al. (2007) The progress on genetic analysis of nasopharyngeal carcinoma. Comp Funct Genomics. 57513 p.
8. Sheu JJ, Lee CH, Ko JY, Tsao GS, Wu CC, et al. (2009) Chromosome 3p12.3- p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma. Cancer Epidemiology, Biomarkers & Prevention 18: 2709-2716.
9. Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, et al. (2004) A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Research 64: 1972-1974.
10. Tse KP, Su WH, Chang KP, Tsang NM, Yu CJ, et al. (2009) Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. American Journal of Human Genetics 85: 194-203.
11. Lu SJ, Day NE, Degos L, Lepage V, Wang PC, et al. (1990) Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 346: 470-471.
12. Bei JX, Li Y, Jia WH, Feng BJ, Zhou G, et al. (2010) A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nature Genetics 42: 599-603.
13. Deng L ZX, Pan KF, Wang Y, Deng XY, Lu YY, et al. (2002) Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34: 16-20.
14. Ooi EE, Ren EC, Chan SH (1997) Association between microsatellites within the human MHC and nasopharyngeal carcinoma. International Journal of Cancer 74: 229-232.
15. Nazar-Stewart V, Vaughan TL, Burt RD, Chen C, Berwick M, et al. (1999) Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiology, Biomarkers & Prevention 8: 547-551.
16. Lerman MI, Sakai A, Yao KT, Colburn NH (1987) DNA sequences in human nasopharyngeal carcinoma cells that specify susceptibility to tumor promoterinduced neoplastic transformation. Carcinogenesis 8: 121-127.
17. Song LB, Liao WT, Mai HQ, Zhang HZ, Zhang L, et al. (2006) The clinical significance of twist expression in nasopharyngeal carcinoma. Cancer Letters 242: 258-265.
18. Cheung ST HD, Hui AB, Lo KW, Ko CW, Tsang YS, et al. (1999) Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein- Barr virus. International Journal of Cancer 83: 121-126.
19. Tsao SW, Wang X, Liu Y, Cheung YC, Feng H, et al. (2002) Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 1590: 150-158.
20. Purcell S NB, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. (2007) PLINK: a toolset for whole-genome association and population-based linkage analysis. American Journal of Human Genetics 81: 559-575.
21. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
22. Tai AL, Mak W, Ng PK, Chua DT, Ng MY, et al. (2006) High-throughput lossof- heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers. Cancer Research 66: 4133-4138.
23. Dutt A, Beroukhim R (2007) Single nucleotide polymorphism array analysis of cancer. Current Opinion in Oncology 19: 43-49.
24. McQuillan R, Leutenegger AL, Abdel-Rahman R, Franklin CS, Pericic M, et al. (2008) Runs of homozygosity in European populations. American Journal of Human Genetics 83: 359-372.
25. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
26. Simon-Sanchez J, Scholz S, Fung HC, Matarin M, Hernandez D, et al. (2007) Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals. Human Molecular Genetics 16: 1-14.
27. Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, et al. (2006) HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 25: 1721-1732.
28. Kim M, Gans JD, Nogueira C, Wang A, Paik J-H, et al. (2006) Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125: 1269-1281.
29. Singh M, Cowell L, Seo S, O'Neill G, Golemis E (2007) Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle. Cell biochemistry and biophysics 48: 54-72.
30. Zheng MZ, Paula MLJ (2002) Regulation of HEF1/NEDD9/CAS-L expression andphosphorylation by TGF-beta 1 and cell adhesion. The Journal of Biological Chemistry 277: 39599-39608.
31. Merrill RA, See AW-M, Wertheim ML, Clagett-Dame M (2004) Crk-associated substrate (Cas) family member, NEDD9, is regulated in human neuroblastoma cells and in the embryonic hindbrain by all-trans retinoic acid. Developmental dynamics: an official publication of the American Association of Anatomists 231: 564-575.
32. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, et al. (2002) Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. The Journal of biological chemistry 277: 5209-5218.
33. Monroe DG, Getz BJ, Johnsen SA, Riggs BL, Khosla S, et al. (2003) Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta. Journal of cellular biochemistry 90: 315-326.
34. Buterin T, Koch C, Naegeli H (2006) Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis 27: 1567-1578.
35. Chen SI, Shi Y, Jin YI, Liu Y, Zhao FT, et al. (2005) Differential gene expression in nasopharyngeal carcinoma cell with reduced and normal expression of 6A8 alpha-mannosidase. Zhongguo yi xue ke xue yuan xue bao Acta Academiae Medicinae Sinicae 27: 305-310.
36. Schuller HM, Al-Wadei HAN, Majidi M (2008) GABA B receptor is a novel drug target for pancreatic cancer. Cancer 112: 767-778.